Medicine Description galvus-met 850 mg
galvus met 850 mg Tablets is a medication that combines two active ingredients, metformin and vildagliptin, to manage blood glucose levels in individuals with type 2 diabetes. Metformin primarily acts by decreasing hepatic glucose production and improving insulin sensitivity in peripheral tissues, which enhances glucose uptake by the cells. This action helps in lowering blood sugar levels effectively. On the other hand, vildagliptin belongs to the class of DPP-4 inhibitors. It works by inhibiting the enzyme dipeptidyl peptidase-4, which is responsible for the degradation of incretin hormones. These hormones, such as GLP-1, augment insulin secretion in response to meals and reduce glucagon release from the pancreas, ultimately leading to decreased blood sugar levels. The synergistic effect of both components of galvus met aids in achieving better glycemic control and can help mitigate the risk of diabetes-related complications.
Indications and Uses of galvus met 850 mg Tablets
- Management of type 2 diabetes mellitus
- Used in conjunction with diet and exercise when blood sugar control is insufficient
- Appropriate for patients requiring combination therapy to enhance glycemic control
Side Effects of galvus met 850 mg Tablets
- Nausea
- Diarrhea
- Abdominal pain
- Headache
- Upper respiratory tract infections
- Hypoglycemia (when combined with other antidiabetic agents)
Storage and Handling
Store galvus met 850 mg Tablets at room temperature, away from direct sunlight and moisture. Ensure that the medication is kept out of reach of children and pets. Do not use the medication after the expiration date indicated on the packaging.
Patient Advice and Precautions
Patients should be advised to maintain a balanced diet and regular exercise as part of their diabetes management plan. Regular monitoring of blood sugar levels is essential to assess the effectiveness of the medication. It is crucial to inform healthcare providers about any other medications being taken to avoid potential interactions. Patients should be aware of the signs of hypoglycemia and how to manage it appropriately. Regular follow-ups with healthcare providers are recommended to ensure optimal diabetes management.